References
- Jaime-Perez JC, Ruiz-Arguelles GJ, Gomez-Almaguer D. Haematopoietic stem cell transplantation to treat aplastic anaemia. Expert Opin Biol Ther 2005;5:617-26 https://doi.org/10.1517/14712598.5.5.617
- Deeg HJ. Graft failure. In : Burt RK, Deeg HJ, Lothian ST, Santos GW editors: On Call in Bone Marrow Transplantation. New York, Chapman & Hill, 1996:306-16
- Stucki A, Leisenring W, Sandmaier BM, Sanders J, Anasetti C, Storb R. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia(a 26-year retrospective analysis). Blood 1998;92: 2742-9
- Davies SM, Weisdorf DJ, Haake RJ, Kersey JH, McGlave PB, Ramsay NK, et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:73-7
- Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med 1997;126:107-15 https://doi.org/10.7326/0003-4819-126-2-199701150-00003
- Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 1982;59:236-46
- Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000;18:3558-85 https://doi.org/10.1200/JCO.2000.18.20.3558
- Gibson FM, Scopes J, Daly S, Ball S, Gordon-Smith EC. Haemopoietic growth factor production by normal and aplastic anaemia stroma in long-term bone marrow culture. Br J Haematol 1995;91:551-61 https://doi.org/10.1111/j.1365-2141.1995.tb05346.x
- Nemunaitis J, Singer JW, Buckner CD, Durnam D, Epstein C, Hill R, et al. Use of recombinant human granulocytemacrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 1990;76:245-53
- Sierra J, Terol MJ, Urbano-Ispizua A, Rovira M, Marin P, Carreras E, et al. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation. Exp Hematol 1994;22:566-72
- Dreger P, Suttorp M, Haferlach T, Loffler H, Schmitz N, Schroyens W. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993;81:1404-7
- Arseniev L, Tischler HJ, Battmer K, Sudmeier I, Casper J, Link H. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSFmobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994;14:791-7
- Hows J, Palmer S, Gordon-Smith EC. Cyclosporine and graft failure following bone marrow transplantation for severe aplastic anaemia. Br J Haematol 1985;60:611-7 https://doi.org/10.1111/j.1365-2141.1985.tb07463.x
- McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994;13:233-7
- de Medeiros CR, Bitencourt MA, Medeiros BC, Ioshizumi L, Pasquini R. Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases. Bone Marrow Transplant 2001;28:941-4 https://doi.org/10.1038/sj.bmt.1703257
- Doney K, Fisher LD, Appelbaum FR, Buckner CD, Storb R, Singer J, et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graftversus- host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991;7:453-9
- Wingard JR, Piantadosi S, Santos GW, Saral R, Vriesendorp HM, Yeager AM, et al. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. J Clin Oncol 1990;8:820-30 https://doi.org/10.1200/JCO.1990.8.5.820
- Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M, et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 2000;111: 292-302 https://doi.org/10.1046/j.1365-2141.2000.02306.x
- Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602 https://doi.org/10.1056/NEJM199303043280901
- Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997;15:433-44 https://doi.org/10.1200/JCO.1997.15.2.433
- Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F, et al. Donor lymphocyte infusions(DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997;19:927-32 https://doi.org/10.1038/sj.bmt.1700762
- Dazzi F, Szydlo RM, Goldman JM. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp Hematol 1999;27:1477-86 https://doi.org/10.1016/S0301-472X(99)00096-X
- Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:2041-50
- Mehta J, Powles R, Treleaven J, Horton C, Meller S, Pinkerton CR, et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997;19:709-19 https://doi.org/10.1038/sj.bmt.1700720
- Wagner JE, Vogelsang GB, Zehnbauer BA, Griffin CA, Shah N, Santos GW. Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy. Bone Marrow Transplant 1992;9:205-9
- Chiang KY, Weisdorf DJ, Davies SM, Enright H, Kersey JH, McGlave PB, et al. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant 1996;17:39-42
- Sanders JE, Buckner CD, Clift RA, Fefer A, McGuffin R, Storb R, et al. Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. Bone Marrow Transplant 1988;3:11-9
- Michallet M, Tanguy ML, Socie G, Thiebaut A, Belhabri A, Milpied N, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol 2000;108:400-7 https://doi.org/10.1046/j.1365-2141.2000.01851.x
- Bosi A, Laszlo D, Labopin M, Reffeirs J, Michallet M, Gluckman E, et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 2001;19:3675-84 https://doi.org/10.1200/JCO.2001.19.16.3675
- Barrett AJ, Locatelli F, Treleaven JG, Gratwohl A, Szydlo R, Zwaan FE. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. Br J Haematol 1991;79:567-74 https://doi.org/10.1111/j.1365-2141.1991.tb08083.x
- Mrsic M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992;9:269-75
- Russell JA, Bowen T, Brown C, Luider J, Ruether JD, Stewart D, et al. Second allogeneic transplants for leukemia using blood instead of bone marrow as a source of hemopoietic cells. Bone Marrow Transplant 1996;18:501-5
- Engelfriet CP, Reesink HW, Wagner JE, Kogler G, Rocha V, Wernet P, et al. International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sang 2002;83:172-87 https://doi.org/10.1046/j.1423-0410.2002.00197.x
- Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003;101:4233-44 https://doi.org/10.1182/blood-2002-08-2510
- Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71 https://doi.org/10.1182/blood.V97.10.2962
- Isoyama K, Ohnuma K, Ikuta K, Toyoda Y, Nakajima F, Yamada K, et al. Unrelated cord blood transplantation for second hemopoietic stem cell transplantation. Pediatr Int 2003;45:268-74 https://doi.org/10.1046/j.1442-200X.2003.01717.x
- Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, et al. Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 1990;75: 555-62
- Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997;19:461-6 https://doi.org/10.1038/sj.bmt.1700680